Columbus Macro LLC Buys 21,684 Shares of Omega Healthcare Investors, Inc. $OHI

Columbus Macro LLC increased its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 11.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 206,784 shares of the real estate investment trust’s stock after acquiring an additional 21,684 shares during the quarter. Columbus Macro LLC owned about 0.07% of Omega Healthcare Investors worth $8,730,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of Omega Healthcare Investors by 3.1% in the second quarter. Vanguard Group Inc. now owns 40,765,481 shares of the real estate investment trust’s stock worth $1,494,055,000 after purchasing an additional 1,210,595 shares during the period. State Street Corp lifted its stake in shares of Omega Healthcare Investors by 4.8% during the 2nd quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust’s stock valued at $534,792,000 after buying an additional 671,473 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Omega Healthcare Investors by 4.6% in the 2nd quarter. Geode Capital Management LLC now owns 7,377,761 shares of the real estate investment trust’s stock worth $270,426,000 after buying an additional 326,595 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in Omega Healthcare Investors by 2.4% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 4,201,353 shares of the real estate investment trust’s stock worth $153,980,000 after buying an additional 100,462 shares during the period. Finally, Bank of New York Mellon Corp increased its stake in Omega Healthcare Investors by 12.8% in the 2nd quarter. Bank of New York Mellon Corp now owns 3,522,082 shares of the real estate investment trust’s stock worth $129,084,000 after buying an additional 398,930 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Price Performance

NYSE:OHI opened at $44.49 on Friday. The business’s 50-day moving average is $43.70 and its 200 day moving average is $41.18. Omega Healthcare Investors, Inc. has a 12 month low of $35.04 and a 12 month high of $46.36. The company has a market capitalization of $13.15 billion, a P/E ratio of 24.85, a P/E/G ratio of 1.97 and a beta of 0.56. The company has a current ratio of 7.11, a quick ratio of 7.11 and a debt-to-equity ratio of 0.95.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.77 by $0.02. The business had revenue of $311.59 million for the quarter, compared to the consensus estimate of $262.48 million. Omega Healthcare Investors had a return on equity of 10.72% and a net margin of 46.83%.The company’s revenue was up 14.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. On average, equities research analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, November 17th. Investors of record on Monday, November 3rd were given a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.0%. The ex-dividend date was Monday, November 3rd. Omega Healthcare Investors’s payout ratio is currently 149.72%.

Insiders Place Their Bets

In other Omega Healthcare Investors news, CEO C Taylor Pickett acquired 20,000 shares of the stock in a transaction on Wednesday, November 5th. The stock was acquired at an average price of $43.14 per share, for a total transaction of $862,800.00. Following the completion of the transaction, the chief executive officer directly owned 20,000 shares of the company’s stock, valued at $862,800. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CIO Vikas Gupta acquired 11,500 shares of the company’s stock in a transaction on Thursday, November 6th. The stock was acquired at an average cost of $42.97 per share, with a total value of $494,155.00. Following the completion of the purchase, the executive directly owned 13,773 shares in the company, valued at approximately $591,825.81. This represents a 505.94% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 1.50% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Jefferies Financial Group restated a “hold” rating and issued a $45.00 price objective on shares of Omega Healthcare Investors in a research report on Monday, December 15th. Mizuho lifted their target price on Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a research note on Thursday, September 11th. Raymond James Financial reissued an “outperform” rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Wells Fargo & Company increased their price objective on shares of Omega Healthcare Investors from $45.00 to $48.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. Finally, UBS Group initiated coverage on shares of Omega Healthcare Investors in a research report on Tuesday, November 18th. They set a “buy” rating and a $50.00 price objective on the stock. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $46.44.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.